NEW YORK--(BUSINESS WIRE)-- SK Capital, a private investment firm with a disciplined focus on the specialty materials, chemicals and healthcare sectors, announced a new organizational structure and additions to the senior management team of the firm’s recently acquired specialty active pharmaceutical ingredient (“API”) and raw materials businesses, Noramco Inc. (“Noramco”) and Tasmanian Alkaloids (“TasAlk”). This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160720005338/en/ Matthew Martin, who was previously the General Manager for the recently acquired businesses has been appointed CEO. Mr. Martin will be supported by a...
↧